|
시장보고서
상품코드
2141392
계란 단백질 가수분해물 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)Egg Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 계란 단백질 가수분해물 시장은 2025년에 2억 4,200만 달러 규모에 달하며, CAGR 6.4%로 성장하며, 2035년까지 4억 4,490만 달러에 달할 것으로 추정되고 있습니다.
| 시장 범위 | |
|---|---|
| 시작연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 초기 시장 규모 | 2억 4,200만 달러 |
| 예측액 | 4억 4,490만 달러 |
| CAGR | 6.4% |
시장 규모는 2025년 15,800킬로톤에서 2035년까지 25,700킬로톤으로 확대될 것으로 예측됩니다. 식품·영양 산업이 기존의 계란 가공에서 부가가치가 더 높은 기능성 원료로 전환됨에 따라 계란 단백질 가수분해물의 상업적 중요성이 높아지고 있습니다. 이 시장의 잠재력은 단백질 함량뿐만 아니라, 단백질을 더 짧은 펩티드 사슬로 분해하는 데 사용되는 제어된 가수분해 공정에도 좌우됩니다. 이 가공 기법을 통해 특정 제제의 소화성, 용해성 및 기능성을 향상시킬 수 있습니다. 고단백 영양, 기능성 원료, 스포츠 영양 및 특수 식이 제품에 대한 소비자의 관심이 높아짐에 따라 달걀 유래 펩티드 원료에 대한 수요가 지원되고 있습니다. 또한 각 제조사는 일관된 펩티드 특성과 용도별 성능을 실현할 수 있는 가공 기술에도 주력하고 있습니다. 확립된 계란 가공 인프라와 고품질 영양 성분에 대한 수요 증가가 맞물리면서 식품, 건강기능식품, 임상 영양 각 분야에서 새로운 기회가 창출되고 있습니다. 원료 개발자들이 가수분해 공정의 최적화와 상용 처방의 확대를 지속함에 따라 달걀 단백질 가수분해물은 2035년까지 더욱 광범위한 용도로 활용될 것으로 기대됩니다.
달걀 흰자 가수분해물 부문은 2025년에 1억 770만 달러의 시장 규모를 기록하며, 2035년까지 연평균 성장률(CAGR) 6.3%로 성장할 것으로 전망됩니다. 달걀 흰자 단백질은 다양한 기능적 특성을 지닌 펩티드계 원료를 개발하기 위한 다채로운 기반을 제공합니다. 그 영양 프로필과 가공의 범용성은 특수 제제로의 활용을 지속적으로 지원하고 있습니다. 달걀 흰자 가수분해물에 대한 연구에서는 빠른 흡수성이 주목받고 있으며, 스포츠 영양 및 임상 영양 분야에서 그 중요성이 유지되고 있습니다. 펩티드 제제 개발이 지속되고 소화하기 쉬운 단백질 원료에 대한 수요가 증가함에 따라 예측 기간 중 해당 부문의 성장이 촉진될 것으로 전망됩니다.
뉴트라슈티컬 용도 부문은 2025년에 6,780만 달러를 기록하고, 2035년까지 1억 1,980만 달러에 달할 것으로 예상됩니다. 계란 유래 펩티드 분획은 소화기 건강, 면역 지원, 심혈관 건강, 항산화 작용 및 항염증 효과를 목적으로 하는 뉴트라슈티컬 제제에 배합되고 있습니다. 기능성 영양 및 건강 지향 원료에 대한 소비자의 관심이 높아짐에 따라 뉴트라슈티컬 분야에서 달걀 단백질 가수분해물에 대한 추가적인 기회가 창출되고 있습니다.
북미의 계란 단백질 가수분해물 시장은 2025년에 9,560만 달러 규모를 기록했습니다. 미국은 2025년에 6,090만 달러 규모의 시장을 창출했으며, 스포츠 영양, 기능성 음료, 영양 보충제, 임상 영양 분야에 서비스를 제공하는 확립된 유통 및 제형 채널의 혜택을 받고 있습니다. 통합된 계란 가공 공급망 또한 원료의 안정적인 공급을 지원하고 있으며, 한편 캐나다는 지역적 가공 능력을 보완하고 수출 지향적인 원료 무역에 기여하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법
제2장 개요
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산·예측 : 소스 유형별, 2025-2035년
제6장 시장 추산·예측 : 프로세스별, 2025-2035년
제7장 시장 추산·예측 : 폼별, 2025-2035년
제8장 시장 추산·예측 : 용도별, 2025-2035년
제9장 시장 추산·예측 : 지역별, 2025-2035년
제10장 기업 개요
KSA 26.10.08The Global Egg Protein Hydrolysates Market was valued at USD 242 million in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 444.9 million by 2035.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $242 Million |
| Forecast Value | $444.9 Million |
| CAGR | 6.4% |
Market volume is projected to increase from 15,800 kilo tons in 2025 to 25,700 kilo tons by 2035. Egg protein hydrolysates are gaining commercial importance as the food and nutrition industries move beyond conventional egg processing toward higher-value functional ingredients. Their market potential depends not only on their protein content but also on the controlled hydrolysis process used to break proteins into shorter peptide chains. This processing approach can improve digestibility, solubility, and functionality for targeted formulations. Growing consumer interest in protein-rich nutrition, functional ingredients, sports nutrition, and specialized dietary products is supporting demand for egg-derived peptide ingredients. Manufacturers are also focusing on processing technologies that can deliver consistent peptide characteristics and application performance. The combination of established egg-processing infrastructure and increasing demand for premium nutritional ingredients is creating opportunities across food, supplement, and clinical nutrition applications. As ingredient developers continue to optimize hydrolysis processes and expand commercial formulations, egg protein hydrolysates are expected to gain broader use through 2035.
Egg white hydrolysates segment held USD 107.7 million in 2025 and is forecast to grow at a CAGR of 6.3% through 2035. Egg white proteins provide a diverse foundation for developing peptide-based ingredients with different functional characteristics. Their nutritional profile and processing versatility continue to support their use in specialized formulations. Research on egg white hydrolysates has highlighted their potential for rapid absorption, which maintains their relevance across sports nutrition and clinical nutrition applications. Continued development of peptide formulations and increasing demand for easily digestible protein ingredients are expected to support segment growth during the forecast period.
Nutraceutical applications segment recorded USD 67.8 million in 2025 and is expected to reach USD 119.8 million by 2035. Egg-derived peptide fractions are incorporated into nutraceutical formulations designed around digestive health, immune support, cardiovascular wellness, antioxidant properties, and anti-inflammatory benefits. Increasing consumer interest in functional nutrition and health-focused ingredients is creating additional opportunities for egg protein hydrolysates within the nutraceutical sector.
North America Egg Protein Hydrolysates Market captured USD 95.6 million in 2025. The United States generated USD 60.9 million in 2025 and benefits from well-established distribution and formulation channels serving sports nutrition, functional beverages, dietary supplements, and clinical nutrition. Integrated egg-processing supply chains also support reliable access to feedstock, while Canada adds regional processing capabilities and contributes to export-focused ingredient trade.
Major companies operating in the global Egg Protein Hydrolysates market include Taiyo Kagaku Co. Ltd., Merck KGaA, Kewpie Corporation, IGRECA, and Rembrandt Foods. Companies in the global Egg Protein Hydrolysates market are strengthening their market foothold through product development, processing technology improvements, capacity expansion, strategic partnerships, and broader distribution networks. Manufacturers are investing in hydrolysis technologies that can improve peptide consistency, solubility, digestibility, and functionality across different formulations. Expanding product portfolios allows companies to address demand from nutraceutical, sports nutrition, clinical nutrition, and functional food applications. Strategic collaborations with food manufacturers, supplement brands, ingredient distributors, and research organizations are helping businesses accelerate formulation development and increase market access. Companies are also optimizing egg-processing and peptide-production operations to improve yields, quality control, and cost efficiency. Geographic expansion is supporting access to new customers and emerging nutrition markets. In addition, businesses are emphasizing technical support, customized ingredient solutions, regulatory compliance, and reliable supply capabilities to build long-term B2B relationships and strengthen their competitive positions.
Table of Contents
Chapter 1. Methodology
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2. Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional
- 2.2.2 Source Type
- 2.2.3 Process
- 2.2.4 Form
- 2.2.5 Application
- 2.3 TAM Analysis, 2025-2035
- 2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
- 2.5 Future Outlook and Strategic Recommendations
Chapter 3. Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier Landscape
- 3.1.2 Profit Margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Industry pitfalls and challenges
- 3.2.3 Market opportunities
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter’s analysis
- 3.6 PESTEL analysis
- 3.7 Price trends
- 3.7.1 By region
- 3.8 Future market trends
- 3.9 Technology and Innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
- 3.10 Patent Landscape
- 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
- 3.12 Sustainability and Environmental Aspects
- 3.12.1 Sustainable Practices
- 3.12.2 Waste Reduction Strategies
- 3.12.3 Energy Efficiency in Production
- 3.12.4 Eco-friendly Initiatives
- 3.13 Carbon Footprint Considerations
Chapter 4. Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 LATAM
- 4.2.1.5 MEA
- 4.2.1 By region
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New Product Launches
- 4.6.4 Expansion Plans
Chapter 5. Market Estimates and Forecast, By Source Type, 2025 - 2035 (USD Million, Kilo Tons)
- 5.1 Key trends
- 5.2 Egg white hydrolysates
- 5.2.1 High-purity protein formulations
- 5.2.2 Allergen-reduced variants
- 5.3 Egg yolk hydrolysates
- 5.3.1 Phospholipid-rich peptides
- 5.3.2 Lipoprotein-functional blends
- 5.4 Whole egg hydrolysates
- 5.4.1 Balanced amino acid profile
- 5.4.2 General-purpose formulations
Chapter 6. Market Estimates and Forecast, By Process, 2025 - 2035 (USD Million, Kilo Tons)
- 6.1 Key trends
- 6.2 Enzymatic hydrolysis
- 6.3 Acid hydrolysis
- 6.4 Other methods
Chapter 7. Market Estimates and Forecast, By Form, 2025 - 2035 (USD Million, Kilo Tons)
- 7.1 Key trends
- 7.2 Powder
- 7.3 Liquid
- 7.4 Capsules/Tablets
Chapter 8. Market Estimates and Forecast, By Application, 2025 - 2035 (USD Million, Kilo Tons)
- 8.1 Key trends
- 8.2 Nutraceuticals
- 8.2.1 Digestive health
- 8.2.2 Immune support
- 8.2.3 Anti-inflammatory functionality
- 8.3 Sports nutrition
- 8.3.1 Pre-workout formulations
- 8.3.2 Post-workout recovery formulations
- 8.3.3 Muscle recovery peptides
- 8.4 Infant & elderly nutrition
- 8.4.1 Hypoallergenic protein blends
- 8.4.2 Easily digestible amino profiles
- 8.5 Clinical nutrition
- 8.5.1 Tube-feeding solutions
- 8.5.2 Recovery diets
- 8.6 Functional food & beverages
- 8.6.1 Bakery mixes
- 8.6.2 Dairy and non-dairy beverages
- 8.7 Cosmetics & personal care
- 8.7.1 Anti-aging skincare
- 8.7.2 Moisturizing applications
- 8.7.3 Barrier-repair formulations
Chapter 9. Market Estimates and Forecast, By Region, 2025 - 2035 (USD Million, Kilo Tons)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East & Africa
Chapter 10. Company Profiles
- 10.1 Kewpie Corporation
- 10.2 Bouwhuis Enthoven BV
- 10.3 Merck KGaA
- 10.4 Rose Acre Farms
- 10.5 Rembrandt Foods
- 10.6 Sanovo Technology Group
- 10.7 Ovostar Union
- 10.8 Pulviver
- 10.9 IGRECA
- 10.10 Taiyo Kagaku Co., Ltd.
- 10.11 Bioseutica
- 10.12 Deb-El Food Products
- 10.13 AgroAlta
- 10.14 EW Group
- 10.15 Ballas Egg
- 10.16 Eurovo Srl
- 10.17 Crystal Lake Farms
- 10.18 Farm Pride Foods
- 10.19 Dalian Hanovo Foods
- 10.20 SOVIMO HELLAS S.A.
